aluates Reports

$ 0.0

Automative

Global PD-1 Inhibitor Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-39Y5795

Global PD 1 Inhibitor Market Insights and Forecast to 2028

BUY CHAPTERS

Global PD-1 Inhibitor Market Research Report 2025

Code: QYRE-Auto-39Y5795

Report

September 2025

Pages:72

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Merck

Novartis

Onxeo

Sumitomo Dainippon Pharma

Taiwan Liposome Company

Tiziana Life Sciences

Genentech (Roche)

Astrazeneca plc

Pfizer Inc

PD-1 Inhibitor Market Size

The global market for PD-1 Inhibitor was valued at US$ 34120 million in the year 2024 and is projected to reach a revised size of US$ 46850 million by 2031, growing at a CAGR of 4.7% during the forecast period.

PD-1 Inhibitor Market

North American market for PD-1 Inhibitor is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for PD-1 Inhibitor is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for PD-1 Inhibitor in Melanoma is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of PD-1 Inhibitor include Merck, Novartis, Onxeo, Sumitomo Dainippon Pharma, Taiwan Liposome Company, Tiziana Life Sciences, Genentech (Roche), AstraZeneca, Pfizer, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for PD-1 Inhibitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PD-1 Inhibitor.

The PD-1 Inhibitor market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global PD-1 Inhibitor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the PD-1 Inhibitor companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of PD-1 Inhibitor Market Report

Report Metric	Details
Report Name	PD-1 Inhibitor Market
Accounted market size in year	US$ 34120 million
Forecasted market size in 2031	US$ 46850 million
CAGR	4.7%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Pembrolizumab Nivolumab Atezolizumab Durvalumab Avelumab Others
Segment by Application	Melanoma Non-small Cell Lung Cancer (NSCLC) Urothelial Carcinoma Classical Hodgkin Lymphoma Renal Cell Carcinoma Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck, Novartis, Onxeo, Sumitomo Dainippon Pharma, Taiwan Liposome Company, Tiziana Life Sciences, Genentech (Roche), AstraZeneca, Pfizer
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of PD-1 Inhibitor company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is PD-1 Inhibitor Market growing?

Ans: The PD-1 Inhibitor Market witnessing a CAGR of 4.7% during the forecast period 2025-2031.

What is the PD-1 Inhibitor Market size in 2031?

Ans: The PD-1 Inhibitor Market size in 2031 will be US$ 46850 million.

Who are the main players in the PD-1 Inhibitor Market report?

Ans: The main players in the PD-1 Inhibitor Market are Merck, Novartis, Onxeo, Sumitomo Dainippon Pharma, Taiwan Liposome Company, Tiziana Life Sciences, Genentech (Roche), AstraZeneca, Pfizer

What are the Application segmentation covered in the PD-1 Inhibitor Market report?

Ans: The Applications covered in the PD-1 Inhibitor Market report are Melanoma, Non-small Cell Lung Cancer (NSCLC), Urothelial Carcinoma, Classical Hodgkin Lymphoma, Renal Cell Carcinoma, Others

What are the Type segmentation covered in the PD-1 Inhibitor Market report?

Ans: The Types covered in the PD-1 Inhibitor Market report are Pembrolizumab, Nivolumab, Atezolizumab, Durvalumab, Avelumab, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global PD-1 Inhibitor Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Pembrolizumab

1.2.3 Nivolumab

1.2.4 Atezolizumab

1.2.5 Durvalumab

1.2.6 Avelumab

1.2.7 Others

1.3 Market by Application

1.3.1 Global PD-1 Inhibitor Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Melanoma

1.3.3 Non-small Cell Lung Cancer (NSCLC)

1.3.4 Urothelial Carcinoma

1.3.5 Classical Hodgkin Lymphoma

1.3.6 Renal Cell Carcinoma

1.3.7 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global PD-1 Inhibitor Market Perspective (2020-2031)

2.2 Global PD-1 Inhibitor Growth Trends by Region

2.2.1 Global PD-1 Inhibitor Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 PD-1 Inhibitor Historic Market Size by Region (2020-2025)

2.2.3 PD-1 Inhibitor Forecasted Market Size by Region (2026-2031)

2.3 PD-1 Inhibitor Market Dynamics

2.3.1 PD-1 Inhibitor Industry Trends

2.3.2 PD-1 Inhibitor Market Drivers

2.3.3 PD-1 Inhibitor Market Challenges

2.3.4 PD-1 Inhibitor Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top PD-1 Inhibitor Players by Revenue

3.1.1 Global Top PD-1 Inhibitor Players by Revenue (2020-2025)

3.1.2 Global PD-1 Inhibitor Revenue Market Share by Players (2020-2025)

3.2 Global PD-1 Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by PD-1 Inhibitor Revenue

3.4 Global PD-1 Inhibitor Market Concentration Ratio

3.4.1 Global PD-1 Inhibitor Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by PD-1 Inhibitor Revenue in 2024

3.5 Global Key Players of PD-1 Inhibitor Head office and Area Served

3.6 Global Key Players of PD-1 Inhibitor, Product and Application

3.7 Global Key Players of PD-1 Inhibitor, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 PD-1 Inhibitor Breakdown Data by Type

4.1 Global PD-1 Inhibitor Historic Market Size by Type (2020-2025)

4.2 Global PD-1 Inhibitor Forecasted Market Size by Type (2026-2031)

5 PD-1 Inhibitor Breakdown Data by Application

5.1 Global PD-1 Inhibitor Historic Market Size by Application (2020-2025)

5.2 Global PD-1 Inhibitor Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America PD-1 Inhibitor Market Size (2020-2031)

6.2 North America PD-1 Inhibitor Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America PD-1 Inhibitor Market Size by Country (2020-2025)

6.4 North America PD-1 Inhibitor Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe PD-1 Inhibitor Market Size (2020-2031)

7.2 Europe PD-1 Inhibitor Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe PD-1 Inhibitor Market Size by Country (2020-2025)

7.4 Europe PD-1 Inhibitor Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific PD-1 Inhibitor Market Size (2020-2031)

8.2 Asia-Pacific PD-1 Inhibitor Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific PD-1 Inhibitor Market Size by Region (2020-2025)

8.4 Asia-Pacific PD-1 Inhibitor Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America PD-1 Inhibitor Market Size (2020-2031)

9.2 Latin America PD-1 Inhibitor Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America PD-1 Inhibitor Market Size by Country (2020-2025)

9.4 Latin America PD-1 Inhibitor Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa PD-1 Inhibitor Market Size (2020-2031)

10.2 Middle East & Africa PD-1 Inhibitor Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa PD-1 Inhibitor Market Size by Country (2020-2025)

10.4 Middle East & Africa PD-1 Inhibitor Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Merck

11.1.1 Merck Company Details

11.1.2 Merck Business Overview

11.1.3 Merck PD-1 Inhibitor Introduction

11.1.4 Merck Revenue in PD-1 Inhibitor Business (2020-2025)

11.1.5 Merck Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis PD-1 Inhibitor Introduction

11.2.4 Novartis Revenue in PD-1 Inhibitor Business (2020-2025)

11.2.5 Novartis Recent Development

11.3 Onxeo

11.3.1 Onxeo Company Details

11.3.2 Onxeo Business Overview

11.3.3 Onxeo PD-1 Inhibitor Introduction

11.3.4 Onxeo Revenue in PD-1 Inhibitor Business (2020-2025)

11.3.5 Onxeo Recent Development

11.4 Sumitomo Dainippon Pharma

11.4.1 Sumitomo Dainippon Pharma Company Details

11.4.2 Sumitomo Dainippon Pharma Business Overview

11.4.3 Sumitomo Dainippon Pharma PD-1 Inhibitor Introduction

11.4.4 Sumitomo Dainippon Pharma Revenue in PD-1 Inhibitor Business (2020-2025)

11.4.5 Sumitomo Dainippon Pharma Recent Development

11.5 Taiwan Liposome Company

11.5.1 Taiwan Liposome Company Company Details

11.5.2 Taiwan Liposome Company Business Overview

11.5.3 Taiwan Liposome Company PD-1 Inhibitor Introduction

11.5.4 Taiwan Liposome Company Revenue in PD-1 Inhibitor Business (2020-2025)

11.5.5 Taiwan Liposome Company Recent Development

11.6 Tiziana Life Sciences

11.6.1 Tiziana Life Sciences Company Details

11.6.2 Tiziana Life Sciences Business Overview

11.6.3 Tiziana Life Sciences PD-1 Inhibitor Introduction

11.6.4 Tiziana Life Sciences Revenue in PD-1 Inhibitor Business (2020-2025)

11.6.5 Tiziana Life Sciences Recent Development

11.7 Genentech (Roche)

11.7.1 Genentech (Roche) Company Details

11.7.2 Genentech (Roche) Business Overview

11.7.3 Genentech (Roche) PD-1 Inhibitor Introduction

11.7.4 Genentech (Roche) Revenue in PD-1 Inhibitor Business (2020-2025)

11.7.5 Genentech (Roche) Recent Development

11.8 AstraZeneca

11.8.1 AstraZeneca Company Details

11.8.2 AstraZeneca Business Overview

11.8.3 AstraZeneca PD-1 Inhibitor Introduction

11.8.4 AstraZeneca Revenue in PD-1 Inhibitor Business (2020-2025)

11.8.5 AstraZeneca Recent Development

11.9 Pfizer

11.9.1 Pfizer Company Details

11.9.2 Pfizer Business Overview

11.9.3 Pfizer PD-1 Inhibitor Introduction

11.9.4 Pfizer Revenue in PD-1 Inhibitor Business (2020-2025)

11.9.5 Pfizer Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Merck

Novartis

Onxeo

Sumitomo Dainippon Pharma

Taiwan Liposome Company

Tiziana Life Sciences

Genentech (Roche)

Astrazeneca plc

Pfizer Inc

List of Tables

Table 1. Global PD-1 Inhibitor Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Pembrolizumab

Table 3. Key Players of Nivolumab

Table 4. Key Players of Atezolizumab

Table 5. Key Players of Durvalumab

Table 6. Key Players of Avelumab

Table 7. Key Players of Others

Table 8. Global PD-1 Inhibitor Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global PD-1 Inhibitor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global PD-1 Inhibitor Market Size by Region (2020-2025) & (US$ Million)

Table 11. Global PD-1 Inhibitor Market Share by Region (2020-2025)

Table 12. Global PD-1 Inhibitor Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 13. Global PD-1 Inhibitor Market Share by Region (2026-2031)

Table 14. PD-1 Inhibitor Market Trends

Table 15. PD-1 Inhibitor Market Drivers

Table 16. PD-1 Inhibitor Market Challenges

Table 17. PD-1 Inhibitor Market Restraints

Table 18. Global PD-1 Inhibitor Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global PD-1 Inhibitor Market Share by Players (2020-2025)

Table 20. Global Top PD-1 Inhibitor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-1 Inhibitor as of 2024)

Table 21. Ranking of Global Top PD-1 Inhibitor Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by PD-1 Inhibitor Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of PD-1 Inhibitor, Headquarters and Area Served

Table 24. Global Key Players of PD-1 Inhibitor, Product and Application

Table 25. Global Key Players of PD-1 Inhibitor, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global PD-1 Inhibitor Market Size by Type (2020-2025) & (US$ Million)

Table 28. Global PD-1 Inhibitor Revenue Market Share by Type (2020-2025)

Table 29. Global PD-1 Inhibitor Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 30. Global PD-1 Inhibitor Revenue Market Share by Type (2026-2031)

Table 31. Global PD-1 Inhibitor Market Size by Application (2020-2025) & (US$ Million)

Table 32. Global PD-1 Inhibitor Revenue Market Share by Application (2020-2025)

Table 33. Global PD-1 Inhibitor Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 34. Global PD-1 Inhibitor Revenue Market Share by Application (2026-2031)

Table 35. North America PD-1 Inhibitor Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. North America PD-1 Inhibitor Market Size by Country (2020-2025) & (US$ Million)

Table 37. North America PD-1 Inhibitor Market Size by Country (2026-2031) & (US$ Million)

Table 38. Europe PD-1 Inhibitor Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 39. Europe PD-1 Inhibitor Market Size by Country (2020-2025) & (US$ Million)

Table 40. Europe PD-1 Inhibitor Market Size by Country (2026-2031) & (US$ Million)

Table 41. Asia-Pacific PD-1 Inhibitor Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 42. Asia-Pacific PD-1 Inhibitor Market Size by Region (2020-2025) & (US$ Million)

Table 43. Asia-Pacific PD-1 Inhibitor Market Size by Region (2026-2031) & (US$ Million)

Table 44. Latin America PD-1 Inhibitor Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Latin America PD-1 Inhibitor Market Size by Country (2020-2025) & (US$ Million)

Table 46. Latin America PD-1 Inhibitor Market Size by Country (2026-2031) & (US$ Million)

Table 47. Middle East & Africa PD-1 Inhibitor Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 48. Middle East & Africa PD-1 Inhibitor Market Size by Country (2020-2025) & (US$ Million)

Table 49. Middle East & Africa PD-1 Inhibitor Market Size by Country (2026-2031) & (US$ Million)

Table 50. Merck Company Details

Table 51. Merck Business Overview

Table 52. Merck PD-1 Inhibitor Product

Table 53. Merck Revenue in PD-1 Inhibitor Business (2020-2025) & (US$ Million)

Table 54. Merck Recent Development

Table 55. Novartis Company Details

Table 56. Novartis Business Overview

Table 57. Novartis PD-1 Inhibitor Product

Table 58. Novartis Revenue in PD-1 Inhibitor Business (2020-2025) & (US$ Million)

Table 59. Novartis Recent Development

Table 60. Onxeo Company Details

Table 61. Onxeo Business Overview

Table 62. Onxeo PD-1 Inhibitor Product

Table 63. Onxeo Revenue in PD-1 Inhibitor Business (2020-2025) & (US$ Million)

Table 64. Onxeo Recent Development

Table 65. Sumitomo Dainippon Pharma Company Details

Table 66. Sumitomo Dainippon Pharma Business Overview

Table 67. Sumitomo Dainippon Pharma PD-1 Inhibitor Product

Table 68. Sumitomo Dainippon Pharma Revenue in PD-1 Inhibitor Business (2020-2025) & (US$ Million)

Table 69. Sumitomo Dainippon Pharma Recent Development

Table 70. Taiwan Liposome Company Company Details

Table 71. Taiwan Liposome Company Business Overview

Table 72. Taiwan Liposome Company PD-1 Inhibitor Product

Table 73. Taiwan Liposome Company Revenue in PD-1 Inhibitor Business (2020-2025) & (US$ Million)

Table 74. Taiwan Liposome Company Recent Development

Table 75. Tiziana Life Sciences Company Details

Table 76. Tiziana Life Sciences Business Overview

Table 77. Tiziana Life Sciences PD-1 Inhibitor Product

Table 78. Tiziana Life Sciences Revenue in PD-1 Inhibitor Business (2020-2025) & (US$ Million)

Table 79. Tiziana Life Sciences Recent Development

Table 80. Genentech (Roche) Company Details

Table 81. Genentech (Roche) Business Overview

Table 82. Genentech (Roche) PD-1 Inhibitor Product

Table 83. Genentech (Roche) Revenue in PD-1 Inhibitor Business (2020-2025) & (US$ Million)

Table 84. Genentech (Roche) Recent Development

Table 85. AstraZeneca Company Details

Table 86. AstraZeneca Business Overview

Table 87. AstraZeneca PD-1 Inhibitor Product

Table 88. AstraZeneca Revenue in PD-1 Inhibitor Business (2020-2025) & (US$ Million)

Table 89. AstraZeneca Recent Development

Table 90. Pfizer Company Details

Table 91. Pfizer Business Overview

Table 92. Pfizer PD-1 Inhibitor Product

Table 93. Pfizer Revenue in PD-1 Inhibitor Business (2020-2025) & (US$ Million)

Table 94. Pfizer Recent Development

Table 95. Research Programs/Design for This Report

Table 96. Key Data Information from Secondary Sources

Table 97. Key Data Information from Primary Sources

Table 98. Authors List of This Report

List of Figures

Figure 1. PD-1 Inhibitor Picture

Figure 2. Global PD-1 Inhibitor Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global PD-1 Inhibitor Market Share by Type: 2024 VS 2031

Figure 4. Pembrolizumab Features

Figure 5. Nivolumab Features

Figure 6. Atezolizumab Features

Figure 7. Durvalumab Features

Figure 8. Avelumab Features

Figure 9. Others Features

Figure 10. Global PD-1 Inhibitor Market Size by Application (2020-2031) & (US$ Million)

Figure 11. Global PD-1 Inhibitor Market Share by Application: 2024 VS 2031

Figure 12. Melanoma Case Studies

Figure 13. Non-small Cell Lung Cancer (NSCLC) Case Studies

Figure 14. Urothelial Carcinoma Case Studies

Figure 15. Classical Hodgkin Lymphoma Case Studies

Figure 16. Renal Cell Carcinoma Case Studies

Figure 17. Others Case Studies

Figure 18. PD-1 Inhibitor Report Years Considered

Figure 19. Global PD-1 Inhibitor Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 20. Global PD-1 Inhibitor Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 21. Global PD-1 Inhibitor Market Share by Region: 2024 VS 2031

Figure 22. Global PD-1 Inhibitor Market Share by Players in 2024

Figure 23. Global Top PD-1 Inhibitor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-1 Inhibitor as of 2024)

Figure 24. The Top 10 and 5 Players Market Share by PD-1 Inhibitor Revenue in 2024

Figure 25. North America PD-1 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. North America PD-1 Inhibitor Market Share by Country (2020-2031)

Figure 27. United States PD-1 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Canada PD-1 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Europe PD-1 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Europe PD-1 Inhibitor Market Share by Country (2020-2031)

Figure 31. Germany PD-1 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. France PD-1 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. U.K. PD-1 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Italy PD-1 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Russia PD-1 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Nordic Countries PD-1 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific PD-1 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Asia-Pacific PD-1 Inhibitor Market Share by Region (2020-2031)

Figure 39. China PD-1 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Japan PD-1 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. South Korea PD-1 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Southeast Asia PD-1 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. India PD-1 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Australia PD-1 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Latin America PD-1 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Latin America PD-1 Inhibitor Market Share by Country (2020-2031)

Figure 47. Mexico PD-1 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Brazil PD-1 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Middle East & Africa PD-1 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Middle East & Africa PD-1 Inhibitor Market Share by Country (2020-2031)

Figure 51. Turkey PD-1 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia PD-1 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. UAE PD-1 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. Merck Revenue Growth Rate in PD-1 Inhibitor Business (2020-2025)

Figure 55. Novartis Revenue Growth Rate in PD-1 Inhibitor Business (2020-2025)

Figure 56. Onxeo Revenue Growth Rate in PD-1 Inhibitor Business (2020-2025)

Figure 57. Sumitomo Dainippon Pharma Revenue Growth Rate in PD-1 Inhibitor Business (2020-2025)

Figure 58. Taiwan Liposome Company Revenue Growth Rate in PD-1 Inhibitor Business (2020-2025)

Figure 59. Tiziana Life Sciences Revenue Growth Rate in PD-1 Inhibitor Business (2020-2025)

Figure 60. Genentech (Roche) Revenue Growth Rate in PD-1 Inhibitor Business (2020-2025)

Figure 61. AstraZeneca Revenue Growth Rate in PD-1 Inhibitor Business (2020-2025)

Figure 62. Pfizer Revenue Growth Rate in PD-1 Inhibitor Business (2020-2025)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global PD 1 and PD L1 Inhibitor Market Research Report 2025

PD 1 and PD L1 Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global PD 1 and PD L1 Monoclonal Antibody Market Research Report 2025

JAK1 Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

PD L1 Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cytokine Inhibitor Market Research Report 2025

Global Tyrosine Kinase Inhibitor Market Research Report 2024

PD 1 PD L1 Inhibitors for Weight Loss Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Immune Checkpoint Agents Market Research Report 2025

Global Tumor Necrosis Factor Inhibitors Market Research Report 2024

Global Anti PD 1 MAb Market Insights Forecast to 2030

Global PD 1 and PDL 1 Inhibitors Market Research Report 2025

Global Non Tyrosine Kinase Inhibitors Market Research Report 2025

Pd 1 and Pd L1 Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancer Growth Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Histone Deacetylase HDAC Inhibitors Market Research Report 2025

Global PD 1 and PD L1 Antibody Market Insights Forecast to 2030

Global Anti PD 1 Antibody Market Insights Forecast to 2030

B Cell Receptor Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions